Chlamydia

Bronnen en Literatuur

Bronnen

• CBS Doodsoorzakenstatistiek. Gegevens omtrent de doodsoorzaken van alle in Nederlandse bevolkingsregisters ingeschreven overledenen.
• SOA-centra. Seksueel Overdraagbare Aandoeningen Peilstation (SOAP)

Literatuur

• Bergen J van, Götz HM, Richardus JH, Hoebe CJPA, Broer J, Coenen AJT.Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation ans suggests targeted screening approaches; results from the first national population based study in the Netherlands. Amsterdam: Sex Transm Infect, 2005; 81: 17-23.
• Bergen J van, Stroucken J, Spanjaard L, Mulder D, Hoek A van den.Urogenital infections with Chlamydia trachomatis in a general practice in Amsterdam Southeast: The need for a more proactive approach. Huisarts Wet, 2000; 43: 210-2.
• Broek IVF van den, Verheij RA, Dijk CE van, Koedijk FDH, Sande MA van der, Bergen JE van.Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers. BMC Fam Pract., 2010; 11: 39.
• CDC, Centers for Disease Control and Prevention.Recommendations for prevention and management of Chlamydia trachomatis infections, 1993. MMWR, 1993; 42: 1-39.
• CDC.Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006; 55: 1-94
• CDC.Chlamydia Screening Among Sexually Active Young Female Enrollees of Health Plans. United States, 2000-2007. MMWR 2009a; 58(14 ): 362-365
• CDC.Sexually Transmitted Disease Surveillance 2007 Supplement. Chlamydia Prevalence Monitoring Project Annual Report 2007. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2009c.
• ECDC, European Centre for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe 2010. Stockholm: ECDC,2010b.
• ECDC, European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe, 1990–2009. Stockholm: ECDC,2011b.
• ECDC.Review of Chlamydia control activities in EU countries. Technical Report. Stockholm: ECDC 2008c.
• ECDC.Chlamydia control in Europe. Guidance. Stockholm: ECDC 2009.
• Egger M, Low N, Smith GD, Lindblom B, Herrmann B.Screening for chlamydial infection and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ, 1998; 316: 1776-80.
• Fenton KA, Lowndes CM.Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect, 2004; 80(4): 255-63.
• Götz HM, Bergen JEAM van, Veldhuijzen IK, Broer J, Hoebe CJPA, Richardus JH.A prediction rule for selective screening of Chlamydia trachomatis infection. Sex. Transm. Inf., 2005; 81: 24-30.
• Hermann B, Egger M.Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis, 1995; 22: 253-60.
• Honey E, Augood C, Templeton A, et al. Cost effectiveness of screening for Chlamydia Trachomatis: a review of the published studies. Sex Transm Infect,2002; 78: 406-12.
• Kamwendo F, Forslin L, Bodin L, Danielsson D.Programmes to reduce pelvic inflammatory disease, the Swedish experience. Lancet, 1998; 351(3): 25-28.
• Laar MJW van de, Duynhoven YTHP van, Beuker RJ, Rijlaarsdam J (red.). SOA en AIDS in Nederland. RIVM-rapport nr. 441500011. Bilthoven: RIVM,2000a.
• Low N, Egger M.What should we do about screening for genital chlamydia? International Journal of Epidemiology, 2002a; 31: 891-893.
• Low N.Current status of chlamydia screening in Europe. Eurosurveillance weekly, 2004; 8(41).
• Low N, Bender N, Nartey L, Shang Aijing, Stephenson J.MEffectiveness of chlamydia screening; systematic review International Journal of Epidemiology, 2009; 38: 435-48.
• Paavonen J, Eggert-Kruse W.Chlamydia trachomatis: impact on human reproduction. Human Reproduction Update, 1999; 5: 433-47.
• Peipert JF.Clinical practice: Genital chlamydial infections. N Engl J Med, 2003; 18(349): 2424-30.
• Risser WL, Risser JMH.The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review. International Journal of STD & AIDS, 2007; 18: 727-31.
• Ross JD.Pelvic inflammatory disease: how should it be managed? Curr Opin Infect Dis., 2003; 16: 37-41.
• TNS Healthcare.Pharmacy Chlamydia Screening Pathfinder Evaluation (PCSPf) Final: Wave Three. November 2005 – December 2007. DH 125331. Londen: Taylor Nelson Sofres, 2007b.
• USPSTF, US Preventive Services Task Force. Screening for Chlamydial Infections. Recommendationas and Rationale. Am J Prev Med,2001b; 20(suppl 3): 90-93.
• USPSTF, US Preventive Services Task Force.Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 147(2): 128-34
• Veldhuizen I, Bergen J van, Götz H, Hoebe C, Morré S, Richardus JH.Reinfections, persistent infections and new infections after general population screening for Chlamydia Trachomatis in the netherlands. Sex Trans Dis, 2005; 32: 599-602.
• Vriend HJ, Koedijk FDH, Broek IVF van den, Veen MG van, Coul ELM Op de, Sighem AI van, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2010. RIVM-rapport nr. 210261009. Bilthoven: RIVM,2011.
• Vries R de, Bergen JEAM van, Jong-van den Berg LTW, Postma MJ.Systematic screening for Chlamydia trachomatis; estimating cost-effectiveness using dynamic modelling and Dutch data. Value in Health, 2006b; 9(1).